Rezolute RZLT
NASDAQ RZLT
$4.01 -0.06 (-1.47%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rezolute (RZLT) Asset Writedowns and Impairment (2018 - 2020)

Updated

Rezolute's Asset Writedowns and Impairment was $23,000 in fiscal Q4 2020 (quarter ended Jun 30, 2020), up 91.7% from $12,000 a year earlier.

Analysis

Rezolute (RZLT) Asset Writedowns and Impairment (2018 - 2020) Analysis & Trends

From fiscal Q4 2018 onward, Rezolute has reported Asset Writedowns and Impairment for 4 quarters.

  • In earlier fiscal years, Asset Writedowns and Impairment was $45,000 in FY2019 (-97.3%) and $1.69 million in FY2018.
  • The fiscal Q4 2020 figure marks the highest quarterly Asset Writedowns and Impairment since fiscal Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Rezolute 386.59 Mn 386.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 23,000.00
Jun 30, 2019 12,000.00
Dec 31, 2018 33,000.00
Jun 30, 2018 1.69 Mn
API Access

Rezolute Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=RZLT&period=max&api_key=YOUR_API_KEY